Speech by Federal Chancellor Dr. Angela Merkel during her visit to the University Hospital Greifswald on July 5, 2013:

Germany Angela Merkel · Former Chancellor of Germany

5 July 2013 · Visit to the University Hospital Greifswald · University Hospital Greifswald, Greifswald, Germany

Context
Merkel addressed faculty, officials, and guests at the inauguration of the new University Hospital Greifswald building on July 5, 2013, highlighting federal investment in medicine and education.
Main themes
University medicine investment, Greifswald University Hospital inauguration, federal and state funding for healthcare, health research and innovation, National Cohort study, cardiovascular research, higher education expansion, student funding and BAföG, Excellence Initiative, demographic change and prosperity, high-tech strategy, prevention and common diseases
Duration
~15 min
51st percentile
Words
1,751
51st percentile
Sentences
107
66th percentile
Readability
42
40th percentile
Grade
11.4
38th percentile
Syntax
2.77
19th percentile
Vocabulary
2.12
31st percentile

Translated from German

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 43%43%
  • Economic 24%24%
  • Ceremonial 21%21%
  • Institutional 7%7%
  • Geopolitical 6%6%
  • Technological 0%0%
  • Environmental 0%0%
  • Not in focus 0%

107 sentences in 27 paragraphs

Dear Rector Weber,

dear Professor Greinacher,

dear Prime Minister,

dear Mayor,

dear District Administrator,

dear Members of Parliament from the federal and state levels,

ladies and gentlemen,

one could say: Greifswald has a new showcase. The university medicine in the Hanseatic city has enjoyed a good reputation for centuries, but with the new building of the university hospital, it receives a face that truly corresponds to this reputation in today's time. Whether doctors, researchers, or students – the new building offers all those who work here better working conditions than they have had before. This allows Greifswald to shine even more with its research-intensive university medicine – and that far beyond the region. The presence of the Prime Minister and myself here also indicates this – as the Rector has already mentioned –: A state-of-the-art new building for university medicine, embedded in a new campus – this is a unique prestige project for Mecklenburg-Vorpommern and a significant gain for Germany. The federal and state governments have won here. Therefore, we can all congratulate each other today.

The diagnostic center here in the central building serves as the symbolic keystone of the construction work. Inaugurating it together corresponds to the significance of the entire construction project. I would like to thank all those who have been involved in the planning and construction of the new university hospital over the many years, as well as those who have managed the move while operations were ongoing.

The federal and state governments have provided around 300 million euros for the new building of university medicine. Researchers, educators, students, and last but not least, of course, the patients benefit from this. This example also shows: Today's investments in innovations will determine tomorrow's prosperity of our country. Therefore, sustainable growth policy is also characterized by a focus on education, science, and research.

The federal government has invested more than 13 billion euros additionally in this area during this legislative period – more than ever before. But it is, of course, also important to use the funds efficiently and purposefully. That is why we have further developed the high-tech strategy. This also concerns the framework program for health research. Our focus is particularly on improving prevention, diagnosis, and therapy of major common diseases. Research results should be brought to clinical application as quickly as possible.

University medicine here in Greifswald plays a particularly important role in this context. Greifswald is a partner site of the German Center for Cardiovascular Research, which is funded by the federal government. Greifswald takes on research tasks regarding multi-resistant pathogens and personalized medicine. Greifswald is also one of 13 university locations nationwide participating in the so-called "National Cohort." This refers to the recently launched and so far largest medical health study in Germany, which is designed to last 20 years and in which around 200,000 people are to participate. We expect this to provide more precise insights into the causes and treatment options for major common diseases.

The top level of university medicine in Greifswald is known far beyond the city limits. That is why it also attracts many students. In this respect, you are right in line with the current trend. Both in terms of the number of first-year students and the total number of students, we have reached record levels in Germany. This is also related to the strong birth cohorts and the partly shortened school years leading up to the Abitur. But especially in these years, it is crucial to offer students good educational prospects, as they will have to shoulder the changes brought about by demographic change. The better educated people are, the better we will succeed in maintaining prosperity.

We have increased the BAföG, expanded talent promotion, and improved study financing with the Deutschlandstipendium. Above all, we must ensure well-equipped study places. This is not always easy, especially in the field of medicine. That is why we have increased the funds of the higher education pact. This will create 300,000 more study places, resulting in a total of over 600,000 new study places by 2015. The federal government is providing around seven billion euros for this, alongside the states. This is our necessary response to the challenges.

However, we are not only concerned with quantity; we have also established the Quality Pact for Teaching to promote innovative teaching approaches. There is also a project for this in Greifswald, namely the "interStudies" project. Furthermore, with the Excellence Initiative, we have opened up new opportunities for universities in research. This has unleashed an unprecedented dynamism in the higher education landscape. This means that it is not just about spending money, but it has also made universities much more competitive in research compared to other research institutions. This initiative helps to bring strengths to light and expand them, thereby increasing the international standing of our universities. This is very important in light of the strong competition. This higher international standing is also evident in the fact that foreign students and researchers are increasingly coming to Germany again.

To ensure the long-term support of higher education institutions by the federal and state governments, the federal government has proposed to amend Article 91 b of the Basic Law accordingly. The federal and state governments still have somewhat differing opinions on this. However, we must see how we can find ways to come together, as cooperation in higher education – also with large research institutions and others – will be of even greater importance in the future than it is today. Ultimately, research does not ask about responsibilities, but about suitable clusters.

Whatever the organization of support for science may be – it is, of course, always associated with certain expectations regarding the support of young researchers. Because ultimately, qualifications today determine our teaching and research level tomorrow. In Germany, young researchers have an open and diverse qualification system available to them. However, there is still a clear need for improvement in some areas.

I also want to explicitly state that, of course, the circumstances of a scientific career in Germany, but also internationally, are often characterized by strong competition. This is inherent to the nature of the matter. But especially when it comes to the issue of reconciling work and family, one encounters certain difficulties. Therefore, I would like to return to the topic of the proportion of women in leadership positions. We have made progress, but today women scientists still hold only 18 percent of professorships and 20 percent of university leadership positions. Greifswald is again at the forefront in this regard. I am, of course, pleased to meet a female rector here.

There is also a need for improvement in the planning and reliability of career paths. Not all uncertainties can be eliminated, of course. There will always be fixed-term projects. But professional personnel management is important, as scientists repeatedly ask themselves: Do we have a perspective in Germany?

That is why I am pleased that I will soon meet with young researchers at the Center of Drug Absorption and Transport – short: C_DAT. This center is an outstanding example of interdisciplinary work. Research groups from the medical and mathematical-natural sciences faculties are jointly investigating how the processes of absorption and transport of active substances in the body occur. As one of those who is waiting for the day when absorption occurs precisely at the point where the body really needs the active ingredient, I view this research project very positively. I believe that there is still a lot to be done to also mitigate the side effects of medications. However, it is always impressive to see how progress is being made here.

The C_DAT is a national research center that has been jointly established by the federal and state governments. We have shared the costs of around 17.6 million euros. In this respect, the C_DAT is further evidence that collaboration between the federal and state governments can also be fruitful in research construction.

The center is also a good example of what targeted support for research and innovation enables in the eastern German states. Mecklenburg-Vorpommern is, I believe, not particularly known for the largest industrial corporations. With an economy characterized by small and medium-sized enterprises, the share of companies in R&D expenditures is correspondingly low. This is a particular challenge from the perspective of the federal government.

That is why we have established a program called "Companies Region," which aims to develop sustainable regional cooperation between universities, research institutions, and companies, thereby strengthening the regional research landscape. In Greifswald, the funding amount for top research and innovation in medicine and for cooperating institutions is around 95 million euros. So there is also excellent networking here.

Dear Rector Weber, dear Professor Greinacher, the federal government stands by its commitment to education and research, to excellence. This is also a fundamental prerequisite for being able to compete internationally. The C_DAT has submitted an application for funding for an InnoProfile transfer project to the Federal Ministry of Education and Research. The project aims to optimize test systems at the laboratory level for practical use. The application was recently approved. Project funding from the federal government in the amount of around 1.6 million euros has been granted until 2016. The total volume, including the contribution from the economy, amounts to 2.1 million euros. This guarantees that something can be done here and that it is not just about having beautiful new buildings.

With the campus and this state-of-the-art building complex, you have a jewel of research in a new form – a jewel that does not only shine in secret but creates real added value as a practical facility. What you see here is, as I must say, architecturally very successful. When you are in this lecture hall – I discussed this with Mr. Sellering earlier – you almost want to start studying again.

Anyone who is engaged here knows that they are not only working for themselves but also for the most precious asset of people, namely their health. You have outstanding conditions for this, for which I congratulate you. Universities are, so to speak, the heart chamber of the innovation location Germany – and that is also the case here in Greifswald.

In my thanks, I would also like to include all those who support research, who help patients: the nurses, the many technicians, those who make this place a site of lived innovation. Thank you very much for allowing me to be here today. I wish you a beautiful new home.